Asia-Pacific – a Global hub for Hepatology Clinical Trials
Liver diseases are highly prevalent in the Asia-Pacific region. The region hosts some of the most active key opinion leaders and investigators with strong experience working with biotechnology companies on hepatology trials.
Clinical Trial Continuity in Asia-Pacific June 2020
Sites across the Asia-Pacific region have quickly changed how they manage trials, and most are able to deliver the clinical trial services their clients need. Biotech companies are currently initiating more clinical trials in Asia and Australia/New Zealand than in North America.